|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's range||25.51 - 25.73|
|52-week range||25.03 - 28.52|
|Beta (5Y monthly)||1.60|
|PE ratio (TTM)||3.00|
|Forward dividend & yield||1.72 (6.72%)|
|Ex-dividend date||04 Aug 2022|
|1y target est||N/A|
LONDON, October 04, 2022--Citi today released a Global Perspectives & Solutions (Citi GPS) report titled Philanthropy and the Global Economy v2.0 – Reinventing Giving in Challenging Times. While conflict in Ukraine has catalysed giving globally in 2022, economic headwinds now risk creating a triple squeeze on philanthropic giving as charities face higher costs, more demand for their services, and declining funding. This report looks at ways in which philanthropy can innovate to unlock the funds
NEW YORK, September 27, 2022--Citi’s Issuer Services business, acting through Citibank, N.A., has been appointed by Joincare Pharmaceutical Group Industry Co., Ltd. ("Joincare") – an innovative and scientific research-oriented pharmaceutical group engaged in the research and development, production and distribution of pharmaceuticals and healthcare products – to act as Depositary Bank for its Global Depositary Receipt ("GDR") program.
NEW YORK, September 26, 2022--Citigroup will issue its third quarter results via press release at approximately 8 a.m. (ET) on Friday, October 14, 2022. At 11 a.m. (ET), results will be reviewed via live webcast and teleconference.